Rebiotix Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 65

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Latest Deal Amount
  • $700K

Rebiotix General Information

Description

Developer of human microbe drugs designed for the treatment of gastrointestinal diseases. The company's drug represents a new approach to the treatment of diseases by delivering live, human-derived microbes into a sick patient's intestinal tract, enabling healthcare providers to cure challenging diseases and recurrent infections.

Contact Information

Formerly Known As
MikrobEX, Trans Biome, Mikrobex Inc.
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2660 Patton Road
  • Roseville, MN 55113
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 2660 Patton Road
  • Roseville, MN 55113
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rebiotix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 22-Dec-2022 $700K Completed Clinical Trials - Phase 3
7. Merger/Acquisition 05-Apr-2018 Completed Clinical Trials - Phase 3
6. Later Stage VC 05-Sep-2017 Completed Clinical Trials - Phase 3
5. Later Stage VC Completed Clinical Trials - Phase 3
4. Early Stage VC (Series B) 04-Aug-2014 Completed Product Development
3. Accelerator/Incubator 01-Jan-2013 Completed Startup
2. Early Stage VC (Series A) 15-Dec-2011 $5M Completed Startup
1. Early Stage VC (Series 1) 04-Nov-2011 $5M $5M Completed Startup
To view Rebiotix’s complete valuation and funding history, request access »

Rebiotix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series 2
Series 1
To view Rebiotix’s complete cap table history, request access »

Rebiotix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of human microbe drugs designed for the treatment of gastrointestinal diseases. The company's drug represents
Drug Discovery
Roseville, MN
65 As of 2020

Malvern, PA
 

Aberdeen, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rebiotix Competitors (66)

One of Rebiotix’s 66 competitors is Venatorx Pharmaceuticals, a Venture Capital-Backed company based in Malvern, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Venatorx Pharmaceuticals Venture Capital-Backed Malvern, PA
NovaBiotics Venture Capital-Backed Aberdeen, United Kingdom
OrphoMed Venture Capital-Backed San Francisco, CA
Enterome Venture Capital-Backed Paris, France
Emerald Health Pharmaceuticals Venture Capital-Backed San Diego, CA
You’re viewing 5 of 66 competitors. Get the full list »

Rebiotix Patents

Rebiotix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025054086-A1 Microbiota restoration therapy (mrt) compositions and methods of administration Inactive 06-Sep-2023
WO-2019241523-A1 Microbiota restoration therapy (mrt) compositions and methods of manufacture Inactive 14-Jun-2018
AU-2018347619-A1 Microbiome health index Inactive 13-Oct-2017
CA-3076359-A1 Microbiome health index Inactive 13-Oct-2017
EP-3695017-A1 Microbiome health index Inactive 13-Oct-2017 C12Q1/689
To view Rebiotix’s complete patent history, request access »

Rebiotix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rebiotix Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aspen Venture Venture Capital Minority
JVC Investment Partners Family Office Minority
Lateral Capital Management Venture Capital Minority
Sofia Fund Angel Group Minority
Springboard Enterprises Accelerator/Incubator Minority
You’re viewing 5 of 6 investors. Get the full list »

Rebiotix FAQs

  • When was Rebiotix founded?

    Rebiotix was founded in 2011.

  • Where is Rebiotix headquartered?

    Rebiotix is headquartered in Roseville, MN.

  • What is the size of Rebiotix?

    Rebiotix has 65 total employees.

  • What industry is Rebiotix in?

    Rebiotix’s primary industry is Drug Discovery.

  • Is Rebiotix a private or public company?

    Rebiotix is a Private company.

  • What is Rebiotix’s current revenue?

    The current revenue for Rebiotix is .

  • How much funding has Rebiotix raised over time?

    Rebiotix has raised $38.5M.

  • Who are Rebiotix’s investors?

    Aspen Venture, JVC Investment Partners, Lateral Capital Management, Sofia Fund, and Springboard Enterprises are 5 of 6 investors who have invested in Rebiotix.

  • Who are Rebiotix’s competitors?

    Venatorx Pharmaceuticals, NovaBiotics, OrphoMed, Enterome, and Emerald Health Pharmaceuticals are some of the 66 competitors of Rebiotix.

  • When was Rebiotix acquired?

    Rebiotix was acquired on 22-Dec-2022.

  • Who acquired Rebiotix?

    Rebiotix was acquired by Ferring.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process